Rebecca Liang

Stock Analyst at Bernstein

(4.51)
# 1,088
Out of 5,125 analysts
83
Total ratings
75%
Success rate
24.6%
Average return

Stocks Rated by Rebecca Liang

Innovent Biologics, Inc.
Nov 2, 2026
Reiterated: Buy
Price Target: $115.00 → $128.00
Current: $88.50
Upside: +44.63%
Hansoh Pharmaceutical Group Company Limited
Nov 2, 2026
Reiterated: Buy
Price Target: $47.00 → $44.00
Current: $34.46
Upside: +27.68%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 2, 2026
Reiterated: Buy
Price Target: $526.00
Current: $465.80
Upside: +12.92%
Akeso, Inc.
Nov 2, 2026
Reiterated: Hold
Price Target: $104.00
Current: $88.70
Upside: +17.25%
BeOne Medicines AG
Mar 18, 2026
Reiterated: Buy
Price Target: $412
Current: $424.00
Upside: -2.83%
CSPC Pharmaceutical Group Limited
Feb 9, 2026
Reiterated: Hold
Price Target: $10.70
Current: $8.57
Upside: +24.85%
Sino Biopharmaceutical Limited
Feb 9, 2026
Reiterated: Hold
Price Target: $7.90
Current: $5.56
Upside: +42.21%
Zai Lab Limited
Feb 9, 2026
Reiterated: Hold
Price Target: $18.00
Current: $20.96
Upside: -14.12%